Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-20
    E.g., 2018-09-20

Archive Search

10 results
12:00 AM, Aug 17, 2015  |  BioCentury | Product Development

Structure knows best

to Heptares co-founder, Chairman and CEO Malcolm Weir, the unit built its StaR platform for GPCR
more amenable for development in the clinic," he said. StaR uses point mutations to stabilize GPCRs …
used in either high throughput screening or X-ray crystallography to determine their structure. Without stabilization, GPCRs …
12:00 AM, May 13, 2013  |  BioCentury | Product Development

An association for dissociation

acute setting, as well as the development of additional programs based on biased interaction with GPCRs …
based on the theory that ligands that selectively activate or antagonize signaling pathways downstream of GPCRs …
could have a better therapeutic index than traditional GPCR-targeting molecules. That's because biased ligands are screened …
12:00 AM, Aug 22, 2011  |  BioCentury | Product Development

Beta testing GPR40

dead, while 30% are either functional or non-responsive cells. GPR40 is a G protein-coupled receptor (GPCR
12:00 AM, Jun 20, 2011  |  BioCentury | Product Development

Broadening immunology's reach

of the histamine H4 receptor ( HRH4 ; H4) in early development. H4 is a GPCR
12:00 AM, Aug 23, 2010  |  BioCentury | Product Development

Gamma no-go

APP" than directly hitting gamma secretase's active site. Fischer noted that GPR3 is an orphan GPCR
12:00 AM, Jan 14, 2008  |  BioCentury | Product Development

Have signal; want potency

to as 19AJ but J&J preferred to call GDIR, is an orphan G protein-coupled receptor (GPCR
12:00 AM, Mar 26, 2007  |  BioCentury | Product Development

Metabolic Milestones

moving through the clinic that antagonize the cannabinoid CB1 receptor , a G protein-coupled receptor (GPCR
12:00 AM, May 15, 2006  |  BioCentury | Product Development

PPAR plus

Mouney, co-founder, chairman and CEO. "We've shown in animals that it also acts on a GPCR
12:00 AM, Feb 06, 2006  |  BioCentury | Product Development

Breathless opportunities

been linked to the recruitment of inflammatory cells through activation of chemokine G protein-coupled receptors (GPCRs …
D2 receptor . PGD2, more commonly known as chemoattractant receptor homolog CRTH2 , is a GPCR
unit of Johnson & Johnson (JNJ, New Brunswick, N.J.), to develop oral antagonists against a GPCR
12:00 AM, May 09, 2005  |  BioCentury | Product Development

Plucking from pharma

stomach. Its mechanism of action is poorly understood, according to Geesaman. "Its receptor is a GPCR